Mock James M 4

What Happened

• James M. Mock, Chief Financial Officer of Moderna, had 11,797 restricted stock units (RSUs) convert into 11,797 common shares on March 5, 2026. To satisfy tax withholding, 5,704 of those shares were withheld at $57.80 per share, totaling $329,691. The net shares delivered to Mock were 6,093.
• This was not an open-market purchase or sale for investment gain/loss—it's RSU vesting (an award converting to stock) with a routine share-withholding to cover taxes.

Key Details

• Transaction date: March 5, 2026; Filing date: March 6, 2026 (filed promptly).
• Vesting/conversion: 11,797 RSUs converted to 11,797 common shares (transaction code M — exercise/conversion of derivative).
• Tax withholding: 5,704 shares withheld at $57.80 per share for $329,691 (transaction code F — payment of tax liability via share withholding).
• Net shares received: 6,093 common shares.
• Shares owned after the transaction: not specified in the provided filing.
• Footnotes: F1 — RSUs convert one-for-one into common stock; F2 — shares were withheld at Mock’s election to satisfy tax withholding; F3 — award vesting schedule notes 25% vested on Dec 5, 2025, remainder vests in 12 equal quarterly installments.
• Filing timeliness: appears timely (filed one day after the vesting date).

Context

• This was a routine equity award vesting event, not a market sale. Withholding shares to cover taxes is common and does not necessarily indicate a view on the stock.
• The derivative entries reflect conversion/cancellation of the RSU award; the $0 disposed entry indicates the RSU instrument was converted (cancelled) rather than sold for cash.